Visco VisionTPE:6782 -1.55%93 ROA % is 16.99% as of Dec. 2025, which is 16% above its 10-year median of 14.66. GuruFocus rates TPE:6782 with a GF Score™ of 93/100 and a GF Value™ of NT$324.46 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 858 Medical Devices & Instruments companies, Visco Vision ranks better than 94.76% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Visco Vision's annualizedNet Income for the quarter that ended in Dec. 2025 was NT$1,004 Mil.
Visco Vision's average Total Assets over the quarter that ended in Dec. 2025 was NT$5,910 Mil. Therefore, Visco Vision's annualized ROA % for the quarter that ended in Dec. 2025 was 16.99%.
The historical rank and industry rank for Visco Vision's ROA % or its related term are showing as below:
TPE:6782'
s ROA % Range Over the Past 10 Years
Min: 6.02 Med: 14.66 Max: 22.85
Current: 15.7
During the past 9 years, Visco Vision's highest ROA % was 22.85%. The lowest was 6.02%. And the median was 14.66%.
TPE:6782's ROA % is ranked better than 94.76% of 858
companies
in the Medical Devices & Instruments industry
Industry Median: 0.545
vs TPE:6782: 15.70
Visco Vision (TPE:6782) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Visco Vision ROA % Related Terms
Visco Vision ROA % Historical Data
* Premium members only.
The historical data trend for Visco Vision's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Visco Vision's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Visco Vision ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Visco Vision's ROA % distribution charts can be found below:
* The bar in red indicates where Visco Vision's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Visco Vision (TPE:6782) has a ROA % of 16.99% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Visco Vision and its competitors. This is 16% above median its historical median of 14.66. Over the past decade, Visco Vision's ROA % has ranged from 6.02 to 22.85. According to the industry distribution chart, Visco Vision ranks #45 out of 858 companies in the Medical Devices & Instruments industry, placing it in the top 5.2%.
Is Visco Vision's ROA % too high?
Visco Vision's current ROA % of 16.99% is 16% above median its 10-year median of 14.66. Over the past 10 years, this metric has ranged from a low of 6.02 to a high of 22.85. The Medical Devices & Instruments industry median ROA % is 0.55. Visco Vision's value of 16.99% is 3017.4% above this industry median. Based on the distribution chart, Visco Vision ranks #45 out of 858 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Visco Vision has a GF Score™ of 93/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Visco Vision's ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Visco Vision ranks #45 out of 858 companies for ROA %. This places Visco Vision in the top 5% of its industry — outperforming the majority of peers. The industry median ROA % is 0.55. Visco Vision's value of 16.99% is 3017.4% above this benchmark. Historically, Visco Vision's own ROA % has ranged from 6.02 to 22.85 over the past decade. While the company's 10-year median is 14.66 vs. the industry median of 0.55, Visco Vision has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.55, based on 858 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Visco Vision's current ROA % of 16.99% is 3017.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Visco Vision and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Visco Vision's current ROA % is 16.99%, which is 16% above median its own 10-year median of 14.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Visco Vision stock overvalued right now?
Based on GuruFocus' analysis, Visco Vision (TPE:6782) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$324.46, compared to a current price of NT$190.00 — trading 41.4% below its estimated fair value. The current ROA % is 16.99%, which is 16% above median its 10-year median of 14.66 and 3017.4% above the Medical Devices & Instruments industry median of 0.55. Visco Vision's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Visco Vision (TPE:6782), the current ROA % is 16.99% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Visco Vision (TPE:6782) Overvalued in 2026?
Based on GuruFocus' analysis, Visco Vision stock appears to be undervalued.
The current stock price of NT$190.00 is trading 41.4% below its estimated GF Value™ of NT$324.46.
GuruFocus considers Visco Vision to be Significantly Undervalued.
Key valuation signals for TPE:6782:
ROA %: 16.99% (16% above median its 10-year median of 14.66)
GF Value™: NT$324.46 vs. price of NT$190.00 (41.4% below fair value)
Industry Position: 3017.4% above the Medical Devices & Instruments median (#45 of 858)
No single metric tells the full story. See the TPE:6782 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Visco Vision Inc is a manufacturer and seller of disposable contact lenses. The company manufactures Spherical Lenses, Multifocal lenses, Toric lenses, and Cosmetic lenses. Geographically, the company earns maximum revenue from Asia, followed by Europe, Taiwan, and the Americas.
93GF Score
Get the complete analysis for TPE:6782
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6782 has been successfully added to your 
